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Topoisomerase V is an archaeal type I topoisomer-
ase that is unique among topoisomerases due to
presence of both topoisomerase and DNA repair
activities in the same protein. It is organized as an
N-terminal topoisomerase domain followed by 24
tandem helix-hairpin-helix (HhH) motifs. Structural
studies have shown that the active site is buried by
the (HhH) motifs. Here we show that the N-terminal
domain can relax DNA in the absence of any HhH
motifs and that the HhHmotifs are required for stable
protein-DNA complex formation. Crystal structures
of various topoisomerase V fragments show changes
in the relative orientation of the domainsmediated by
a long bent linker helix, and these movements are
essential for the DNA to enter the active site. Phos-
phate ions bound to the protein near the active site
helped model DNA in the topoisomerase domain
and show how topoisomerase V may interact with
DNA.INTRODUCTION
DNA topoisomerases are enzymes found in all forms of life
(bacteria, eukarya, and archaea) and they regulate the topolog-
ical state of DNA inside the cell. They form a transient break in
a single or double stranded DNA and allow the passage of
another single or double DNA strand through the break, before
resealing the break (Champoux, 2001; Schoeffler and Berger,
2008). As a result of this, topoisomerases can relax supercoiled
DNA, help in the segregation of DNA strands following replica-
tion, and lead to the formation and resolution of knots and cate-
nates (Schoeffler andBerger, 2008). Topoisomerases participate
inmany aspects of DNAmetabolism, such as replication, recom-
bination, and transcription (Champoux, 2001). In addition, they
are targets of various anti-cancerous drugs and anti-bacterial
agents (Maxwell, 1999; Pommier, 1998; Rothenberg, 1997;
Wang et al., 1997).
DNA topoisomerases are broadly classified into two types,
type I and type II enzymes. Type I enzymes cleave a single strand
of a DNA molecule and pass another single or double strandedStructure 18,DNA through the break before resealing the opening. Type II
enzymes cleave both strands of a double stranded DNA in
concert and pass another double stranded DNA through the
break. Type I enzymes use the torsional energy stored in the
supercoiled DNA to drive DNA relaxation and hence they do
not require high energy cofactors, such as ATP, for their activity
(Baker et al., 2009). Type II enzymes, in contrast, require ATP and
Mg2+ for their activity. Type I topoisomerases are further subdi-
vided into three subtypes: IA, IB, and IC (Forterre et al., 2007).
Type IA and IB enzymes have been studied extensively (Baker
et al., 2009) and there is ample information available about their
general mechanism of DNA relaxation and the mode of DNA
binding. Type IC, however, is a relatively new subtype. Currently
topoisomerase V is the only member of this family and it has
been identified only in theMethanopyrus genus. Previously, top-
oisomerase V had been considered as a type IB enzyme based
on its biochemical characteristics (Slesarev et al., 1993), but
the crystal structure of an N-terminal 61 kDa of topoisomerase
V (Topo-61) (Taneja et al., 2006) revealed a completely new
fold without similarity to other topoisomerases or any other
known protein. Furthermore, the orientation of the putative active
site residues is also different from other type I topoisomerases,
suggesting a different mechanism of cleavage and religation of
DNA. These observations, together with the lack of sequence
similarity, indicated that topoisomerase V defines a new subtype
of type I enzymes (Forterre, 2006).
Topoisomerase V was identified inMethanopyrus kandleri, an
extremophile isolated from a deep-water ‘‘black smoker’’
chimney in the Gulf of California (Huber et al., 1989). The enzyme
is active at very high temperatures (122C) and high salt concen-
trations (0.65 M NaCl and 3.1 M potassium glutamate). The
unusual characteristic of topoisomerase V is that it has both top-
oisomerase and DNA repair activities in the same polypeptide
(Belova et al., 2001). Based on the sequence analysis of topoiso-
merase V, it has been predicted that the protein contains 24
helix-hairpin-helix (HhH) DNA binding motifs arranged as
12 (HhH)2 domains around the N-terminal topoisomerase
domain (Belova et al., 2002) (Figure 1A). Some of these (HhH)2
domains are involved in the apurinic/apyrimidinic site-process-
ing activity, but the exact location of the repair active site is not
known yet. Topoisomerase V can relax both positively and nega-
tively supercoiled DNAwithout the need for metal cations or high
energy cofactors. Single molecule experiments have shown that
topoisomerase V relaxes DNA by a constrained swiveling
mechanism, relaxing around 12 turns of DNAper relaxation cycle829–838, July 14, 2010 ª2010 Elsevier Ltd All rights reserved 829
Figure 1. Organization of Topoisomerase V
Topoisomerase V is a multi-domain protein consisting of 24 HhH DNA binding
motifs arranged as 12 (HhH)2 domains following the N-terminal topoisomerase
domain.
(A) Schematic diagram of various topoisomerase V fragments. The topoiso-
merase domain is shown in red and the (HhH)2 domains are shown in alter-
nating colors of cyan and yellow. The (HhH)2 domains with repair activity are
shown in green. All fragments shown have topoisomerase activity, but only
the full-length protein and the Topo78 fragment have repair activity.
(B) Crystal structure of Topo-61 fragment (Taneja et al., 2006). The coloring
scheme is the same as in (A), except that the linker helix is shown in gray.
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Minimal Catalytic Domain of Topoisomerase V(Taneja et al., 2007). Type IB enzymes, which also use a con-
strained swiveling mechanism for DNA relaxation, relax around
19 turns of DNA per relaxation cycle (Koster et al., 2005).
The structure of Topo-61 showed that the topoisomerase
domain is mainly a helical and that the first four (HhH)2 domains
curl around the topoisomerase domain (Taneja et al., 2006)
(Figure 1B). The topoisomerase and (HhH)2 domains are joined
by a long bent helix, termed the ‘‘linker helix.’’ Three of the five
putative active site residues are present in a helix-turn-helix
(HTH) domain and the other two are present in an intervening
loop and a helix. The active site residues are buried by the first
(HhH)2 domain and it has been suggested that large conforma-
tional changes will be needed for the DNA to access the active
site of topoisomerase V (Taneja et al., 2007). Here we present
data that shows that the N-terminal 31 kDa fragment of topoiso-
merase V (Topo-31) has topoisomerase activity, consistent with
previous predictions based on the structure. In addition, we
show that the Topo-44 fragment (N-terminal 44 kDa fragment
of topoisomerase V) can form a stable protein-DNA complex,830 Structure 18, 829–838, July 14, 2010 ª2010 Elsevier Ltd All rightemphasizing the need of the (HhH)2 domains for binding DNA.
We determined a crystal structure of (Topo-31) fragment, which
has only the topoisomerase domain, and three different crystal
structures of the Topo-44 fragment, which includes the topoiso-
merase domain and three tandem HhH motifs. In all structures,
the topoisomerase domain is very similar. In contrast, the struc-
tures of Topo-44 show conformational changes in the linker helix
resulting in variable orientations of the (HhH)2 domains when
compared to the Topo-61 structure. Phosphate ions are present
in the vicinity of the topoisomerase active site in two of the Topo-
44 structures. Some of the catalytic residues interact with the
phosphate ions andmaymimic contacts with DNA. These obser-
vations suggest that the movement of the (HhH)2 domains is
mediated by the linker helix and helps expose the topoisomerase
active site to facilitate DNA binding. In addition, the location of
the phosphate ions suggests a possible path for the DNA and
the way the active site residues interact with it.
RESULTS
The Topoisomerase Domain Can Relax DNA by Itself
DNA relaxation assays using different topoisomerase V frag-
ments showed that the topoisomerase domain alone is capable
of relaxing DNA. Topoisomerase V fragments with different
numbers of (HhH)2 domains, Topo-31, Topo-44, and Topo-78
were studied using relaxation assays. Topo-31 has no (HhH)2
domains, Topo-44 has one full and one partial (HhH)2 domain,
while Topo-78 has eight full (HhH)2 domains, including a putative
DNA repair domain. In addition to standard conditions, the effect
of different pH conditions and presence of magnesium ions were
also tested. The experiments show that Topo-31 is capable of re-
laxing DNA, despite the absence of the (HhH)2 domains
(Figure 2B). A pH profile analysis for the DNA relaxation assays
showed that Topo-78 relaxes DNA over a wider pH range
(pH 5 to 9), while Topo-31 and Topo-44 relax DNA optimally
at pH 5 (Figures 2A–2C). In addition, magnesium is not required
for the reaction, but stimulates it at all pH values (Figures 2B and
2C). Topo-78 can relax DNA to the same extent with lower
amounts of protein (0.1 mg/reaction) compared to Topo-44
(1.5 mg/reaction) and Topo-31 (9 mg/reaction). This could be
due to the enhanced DNA binding facilitated by the (HhH)2
domains. Together, these results suggest that, even though
the (HhH)2 domains are dispensable for topoisomerase activity,
they enhance DNA relaxation activity. In addition, the pH depen-
dence of the DNA relaxation activity indicates that the reaction is
likely to involve side chains with ionizable groups in the low pH
range, such as glutamates. Finally, the magnesium indepen-
dence of the reactions confirms that even the smallest fragments
do not require metals for activity, although magnesium has
a stimulatory effect. This may be due to favorable interactions
of the cations with DNA.
The (HhH)2 Domains Enhance DNA Binding Affinity
Electrophoretic mobility shift assay (EMSA) experiments with
different fragments of topoisomerase V and DNA showed that
(HhH)2 domains could help in the formation of a stable protein-
DNA complex. Various topoisomerase V fragments (Topo-31,
Topo-44, and Topo-78) and single and double stranded DNA
were analyzed by EMSA experiments. Topo-44 and Topo-78s reserved
Figure 2. DNARelaxation Activity and EMSA for Topo-
31, Topo-44, and Topo-78 Fragments of Topoisomer-
ase V
(A) pH profile of the DNA relaxation activity of Topo-78 and
Topo-44 fragments. 0.2 mg of pUC19 DNA were incubated
with 0.1 mg of Topo-78 or 1.5 mg of Topo-44 proteins at
65C for 15 min for the relaxation reaction. The reaction buffer
contained 50 mM of the appropriate buffer, 30 mM NaCl, and
0.2 mM EDTA. Topo-78 relaxes DNA at a wider pH range (5 to
9) than Topo-44, which relaxes DNA efficiently only at pH 5.
(B and C) DNA relaxation activity of Topo-31 (B) and Topo-44
(C) fragments in the absence and presence of MgCl2. 0.2 mg of
pUC19 DNA were incubated with 9 mg of Topo-31 or 1.5 mg of
Topo-44 proteins at 65C for 15min for the relaxation reaction.
The reaction buffer contained 50mMof the appropriate buffer,
30 mM NaCl, and 5 mM EDTA or 1 mM MgCl2. Both Topo-31
and Topo-44 fragments can relax DNA in the absence of
MgCl2, but MgCl2 enhances the DNA relaxation activity of
the topoisomerase V fragments. The black triangle in (A)–(C)
represents increasing pH from 4 to 10 by one pH unit.
(D) EMSA of Topo-44 and Topo-78 fragments with a 39-mer
double stranded DNA. Both Topo-44 and Topo-78 form stable
complexes with DNA, although Topo-78 seems to saturate
DNA binding while Topo-44 does not. In addition, Topo-44
shows some cleavage of the DNA (bottom, free DNA band),
while the cleavage is not apparent in Topo-78. The numbers
at the bottom represent the molar ratio of protein to DNA.
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Minimal Catalytic Domain of Topoisomerase Vformed stable complexes with a 39-mer double stranded DNA
(Figure 2D), while no DNA binding was observed for the Topo-
31 fragment (data not shown). These observations indicate that
(HhH)2 domains are necessary for a stable protein-DNA complex
and that as few as one and half (HhH)2 domains are enough for
formation of a stable protein-DNA complex. EMSA with single
stranded DNA showed that Topo-31 and Topo-44 cannot bind
to single stranded DNA, while Topo-78 can bind to single
stranded DNA (data not shown).Overall Structures
The topoisomerase domain of topoisomerase V is a helical-rich
compact domain that has no structural similarity to any other
known protein. The only recognizable structural element is
a HTH that contains some of the active site residues. Not surpris-
ingly, the topoisomerase domain of the four structures (Topo-31
and Topo-44 Forms I, II, and III) superimpose very well on each
other and also to that from the Topo-61 structure. In the Topo-
31 structure, two surface loops, residues 39–49 and 120–124,
adopt a different conformation compared to the Topo-61 and
Topo-44 structures. These two loops are not always visible in
the Topo-44 structures, suggesting that they are mobile regions.
The rmsd for the superposition of the topoisomerase core
domain of all the new structures on to the Topo-61 structure
range from 0.2 A˚ to 0.7 A˚ if the two mobile surface loops are
not included (Figure 3A). In general, the topoisomerase domain
remains unchanged and is identical in all structures. The
(HhH)2 domains also remain largely unchanged, with rmsd for
the superposition of only the (HhH)2 domains from the three
Topo-44 crystal forms and equivalent domains in the Topo-61
structure ranging from 0.31 A˚ to 0.56 A˚.
The five crystallographically independent structures of Topo-
44 (Form I, Form II A and B monomers, and Form III A and BStructure 18,monomers) were compared with each other and to the two crys-
tallographically independent Topo-61 monomers to understand
the conformational changes in the protein. The rmsd for the
superposition of all the Topo-44 structures (residues 3–375) on
to the Topo-61 fragment or on each other vary between 0.9 A˚
and 2.7 A˚, with the majority above 1.5 A˚, showing that in general
the structures have slightly different conformations. As
mentioned above, the different domains behave as rigid or
almost rigid subunits and the only change in the structure is
the relative orientation between the topoisomerase and the
(HhH)2 domains. The change in orientation of the domains starts
at the linker helix (residues 269–295), which acts as a hinge
region, and follows into the (HhH)2 domains. At the start of the
linker helix, the structures superimpose very well for all five
Topo-44 and two Topo-61 structures. In the middle of the linker
helix there is a kink after which the linker helix from all the struc-
tures shows different orientations (Figure 3B). The flexibility of
the linker helix is also evident by the fact that the linker helix in
the B subunit of Form III crystals appears in two alternate confor-
mations. The change in the relative orientation of the (HhH)2 and
topoisomerase domains (Figures 3C and 3D) suggests that these
domains can adopt different orientations and these movements
might be necessary for the DNA to access the active site.The Topoisomerase Domain Has a Positively Charged
Groove Adjacent to the Active Site
The structure of the Topo-31 as well as the structures of the
Topo-44 fragment reveals the presence of a positively charged
groove in the protein that encompasses the active site region
(shown later in Figure 6C). This charged groove had been
observed before in the structure of the Topo-61 fragment,
although several (HhH)2 motifs partially obstruct it (Taneja
et al., 2006). The structure of the Topo-31 confirms the presence829–838, July 14, 2010 ª2010 Elsevier Ltd All rights reserved 831
Figure 3. Structure of Topo-44 Fragments
(A) Overlay of Form I (green), Form II (B subunit: blue), and
Form III (B subunit: magenta) structures onto the Topo-61
structure (B subunit: orange). The topoisomerase domains
superimpose very well for all the structures, while the linker
helix and (HhH)2 domains show differences in orientation.
(B) Overlay of the linker helices of Form I, II, and III structures
with that of Topo-61. The color scheme is the same for all the
figures unless mentioned otherwise. Note that the linker
helices have the same orientation at the start and they change
as they move further down the helix.
(C) Superposition of Form I, II, and III Topo-44 structures with
that of Topo-61. Only the (HhH)2 domains are coloredwhile the
remaining parts are shown in gray for clarity. The active site
residues are shown as orange sticks. Note that the (HhH)2
domains adopt different orientations in all the structures.
(D) Orientation of the (HhH)2 domains of Form I, Form II, and
Topo-61 structures. In Form I and II structures, the (HhH)2
domains are moved away from the topoisomerase domain.
For clarity, the (HhH)2 domains of Form III are not shown. In
(C) and (D), the topoisomerase domains were superposed to
emphasize the different orientation of the other domains.
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Minimal Catalytic Domain of Topoisomerase Vof the groove even in the absence of the (HhH)2 motifs. The
groove is long and can be deep in some areas. It includes regions
of the HTH motifs and extends all the way to the linker helix. All
the residues forming the active site pentad point toward the
groove. The active site tyrosine, Tyr226, is found near one of
the ends of the groove, a region where it widens. The positively
charged character of the groove and its presence by the active
site strongly suggest that it may be involved in DNA binding.
Phosphate Ions Bind in the Groove Near
the Topoisomerase Active Site
An interesting observation stemming from the Form II and Form
III Topo-44 structures is the presence of phosphate ions near the
positively charged DNA binding groove. All three Topo-44 crystal
forms were crystallized in the presence of phosphate-citrate
buffer, but only Form II and Form III structures showed phos-
phate ions bound to the protein, which were assigned based
on electron density consistent with a tetrahedral phosphate ion
(Figure 4A). Form II and Form III crystals include 1–1.2 M guani-
dium hydrochloride in the crystallization solution. The high reso-
lution Form III structure shows clear density for three guanidium
ions bound to the protein, two very well ordered and one with
weak density. The presence of guanidium hydrochloride in the
crystals appears to trigger a conformational change allowing
the binding of phosphate ions to the protein. It is interesting to832 Structure 18, 829–838, July 14, 2010 ª2010 Elsevier Ltd All rights reservednote that Form I crystals did not show any bound
phosphate, albeit its presence in the crystallization
condition. This could be due to the absence of gua-
nidium hydrochloride to trigger the binding of phos-
phate ions as observed in Form II and Form III
structures. There are three phosphate ions in the
B subunit and none in the A subunit of the Form II
Topo-44 structure. Two of the phosphates are
in the topoisomerase active site and one of them
forms close contacts with the putative active
site residues in the topoisomerase domain (Fig-ure 4B). Form III crystal has seven phosphate ions, three in
each subunit and one between both the subunits. In the Form
III structure, the phosphate ion near the active site tyrosine,
Tyr226, is absent, but it shows several new locations for phos-
phate ions, especially in the positively charged groove contain-
ing the topoisomerase active site (Figure 5A). An overlay of the
A and B subunits of the Topo-44 Form III structure with the B
subunit of Topo-44 Form II structure shows eight unique phos-
phate ions (Figure 5A). It clearly shows that there are more phos-
phate ions bound in the positively charged groove compared to
other regions of the protein.
Taking into account all structures, there are five unique phos-
phate ion binding sites in the putative DNA binding groove and
an additional one near its end and close to the start of the linker
helix. Several pairs of phosphates in the groove are separated by
a distance of around 7 A˚ (Figure 5B), which would be consistent
with the phosphate-phosphate distance in adjacent nucleotides
in a DNA double helix. One of the phosphates (P1) is found near
the active site tyrosine and is coordinated by Tyr226 and Arg131,
two residues that have been implicated in cleavage and religa-
tion of the DNA (Taneja et al., 2006), and by Glu215, whose
charge may be important for interactions with DNA (R.R. and
A.M., unpublished data). The side chains of the tyrosine and
the glutamate residues are in contact with Arg144 and His200,
the other putative active site residues, and these interactions
Figure 4. Phosphate Ions Present Near the Active Site
of the Topo-44 Structure
(A) Stereoview of a Form III difference electron density map
calculated with a model not including the phosphates. The
electron density is contoured at 3.7s and shows the tetrahe-
dral shape of the phosphate ions. The active site residues
are shown in stick.
(B) Stereoview of the interaction of the phosphate ions with the
putative active site residues. The B subunit of Form II structure
was superimposed onto the B subunit of Form III structure and
the phosphates ions from both structures are shown together
with the Form II B subunit protein backbone. The interactions
made by the phosphate ion with the active site residues and
the corresponding distances in angstroms are represented
as black dotted lines.
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Minimal Catalytic Domain of Topoisomerase Vmay help to orient them for the catalytic reaction. Adjacent to P1,
there is a second phosphate (P2) at a distance of 7.5 A˚, which is
trapped between the topoisomerase domain and an HhH motif.
P2 is coordinated by Arg131, an active site residue, in addition to
Arg108 from the topoisomerase domain and Arg293 and serines
322 and 324 from the second HhH motif (Figure 6C). Three more
phosphates are found in the groove (P3, P4, and P5) coordinated
mainly by positively charged residues, such as Arg37, Lys47,
Arg108, Lys134, and Arg135, from the topoisomerase domain
and also residues from the linker helix, such as Tyr289 and
Arg293. In general, some of the side chains can contact more
than one phosphate. The distance between P3 and P4 and P4
and P5 is 6.8 A˚ and 6.5 A˚, respectively. A final phosphate (P6)
is located at the start of the linker helix and on the edge of the
groove (Figure 5A).
DISCUSSION
Topoisomerase V is active at very high temperatures (122C) and
high salt concentrations. DNA relaxation assays with various
topoisomerase V fragments (Topo-44 and Topo-61) show that
a temperature above 60C is required for optimal activity,
although longer fragments of topoisomerase V can relax DNA
at lower temperatures (Taneja et al., 2007). Topo-44 was first
identified by limited proteolytic digestion of the full-length topoi-
somerase V protein (Belova et al., 2002) at 80C. In contrast,
Topo-61 is the shortest fragment showing topoisomerase
activity when the proteolytic reaction is performed at 37C
(Belova et al., 2002).The N-terminal Topo-31 fragment, which
contains neither HhH motifs nor the linker helix, was identified
as the smallest region spanning the topoisomerase domainStructure 18, 829–838, Julfrom the crystal structure of Topo-61 fragment
(Taneja et al., 2006) and it was suggested that it
could represent the minimal domain capable of
relaxing DNA. Relaxation experiments with this
minimal domain show that this is indeed the case,
although the activity is not as robust as with longer
fragments. As expected, Topo-31 does not require
magnesium for activity, but magnesium enhances
it, as is the case for type IB topoisomerases, which
also use a swiveling mechanism for DNA relaxation
(Stewart et al., 1996). The optimal pH for activity forthe Topo-31 and the Topo-44 fragments is around 5. This pH
dependence is not observed for the Topo-78 fragment. The
DNA relaxation by shorter fragments of topoisomerase V at pH
5 could point to the involvement of some ionizable side chains
in the relaxation activity. It could also be simply due to the effects
of various side chains on DNA binding. Further experiments with
different active site mutations in both longer and shorter frag-
ments of topoisomerase V will be required to probe the pH
dependence of the relaxation reaction by shorter topoisomerase
V fragments.
Gel shift experiments show that Topo-44 and also longer frag-
ments (Topo-78) can bind double stranded DNA. Surprisingly,
Topo-31 does not show DNA binding activity in these assays
even though it is still capable of relaxing DNA. It appears that
the presence of the (HhH)2 domains stabilizes the protein-DNA
complex. One possibility is that the (HhH)2 domains could play
a similar role to the cap domain present in type IB enzymes,
which helps to encircle the DNA during the swiveling reaction
(Redinbo et al., 1998). In addition, both short fragments of topoi-
somerase V do not bind single stranded DNA, whereas Topo-78
can form a stable complex with single stranded DNA (data not
shown). (HhH)2 domains binding to single stranded DNA has
been observed before. For instance, the N-terminal 8 kDa of
mammalian polymerase b, which contains a single HhH motif,
binds to single stranded DNA through both helices (Kumar
et al., 1990; Liu et al., 1994). The exact mode of single stranded
DNA binding by Topo-78 or the possible role in relaxation or
repair activities is not yet clear.
The structure of Topo-61 showed that the topoisomerase
active site of topoisomerase V is buried by one of the (HhH)2
domains, suggesting that conformational changes are essentialy 14, 2010 ª2010 Elsevier Ltd All rights reserved 833
Figure 5. Representation of the Unique Phosphate Ions from Form II
and Form III Topo-44 Structures
(A) An overlay of the A (magenta) and B (brown) subunits of the Form III struc-
ture and B (blue) subunit of Form II Topo-44 structures. The positions of eight
unique phosphate ions (orange spheres) are shown. Note that most phosphate
ions are found along the DNA binding groove of the topoisomerase domain.
(B) The phosphate ions in the DNA binding groove are separated by distances
of around 7 A˚. The protein backbone is that of the B subunit of Form III struc-
ture. The active site residues are represented as sticks and distances in
angstroms between adjacent phosphate ions are shown as black dotted lines.
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Minimal Catalytic Domain of Topoisomerase Vfor the protein to bind DNA. The present structures of Topo-44
reinforce this observation and show that the (HhH)2 domains
can change their position relative to the topoisomerase domain
and that this change is mediated by the movement of the linker
helix. The (HhH)2 domains act as rigid individual units, as evi-
denced by the fact that in different structures they show the
same structure and relative orientation of the two HhH motifs.
The topoisomerase domain also appears to be rigid, showing
the same structure even in the total absence of the rest of the
protein. The linker helix (residues 269–295), which is a long
bent helix, serves as a hinge for the movement of the (HhH)2
domains away from the rigid topoisomerase domain, possibly
by responding to interactions with double stranded DNA. This834 Structure 18, 829–838, July 14, 2010 ª2010 Elsevier Ltd All rightmovement has to be quite large. The Topo-44 structures in the
absence of DNA capture the regions that move, but do not
show the full extent of the movement or indicate the way the
HhH motifs interact with DNA.
Asmentioned before, topoisomerase V binds double stranded
DNA and has a groove wide enough to accommodate double
stranded DNA (Figure 6C).The presence of an HTH domain nor-
mally associated with DNA binding, the positively charged
nature of it, and several phosphates bound along it suggest
that this groove could be involved in DNA binding. In addition,
the active site is found in this groove and some residues form
part of the HTH domain. Previously, DNA was modeled bound
to the topoisomerase domain (Taneja et al., 2006) based on
the structures of HTH domains in complex with DNA but there
was no evidence to support it. Using the phosphates present
in the groove in the current structures, it is possible to refine
this model. A superposition of the B subunit of Form II and the
A and B subunits of Form III Topo-44 structures shows five
different phosphate ions in the positively charged groove that
are separated by a distance of around 7 A˚, consistent with the
distance of consecutive phosphates in B DNA of 6.4 A˚. A sixth
phosphate ion is found outside the groove near the linker helix. A
double stranded DNA molecule was modeled into the groove
based on the positions of the phosphate ions (Figure 6). Only
five out of the six phosphates could be placed on the DNAmole-
cule, as one of them was inconsistent with a double stranded
molecule. Phosphate ions P3, P4, and P5 would correspond to
three adjacent phosphates in one DNA strand, while P1, located
near the active site, would belong to the opposite strand. A final
phosphate (P6) is away from the groove and near the linker helix
(Figures 6A and 6B). The fit to the four inner phosphates is excel-
lent and the DNA can be accommodated in the groove of the
Topo-31 structure without the need for any major rearrange-
ments of the protein backbone. The fifth phosphate (P6) does
not fit as well and a better fit would require movement of either
the protein or the DNA, but the change would be relatively
modest. Several side chains would need to move, but these
changes would also be minor. The major change needed to
accommodate the DNA in the structures with the (HhH)2
domains present is the movement of the (HhH)2 domains away
from the topoisomerase domain (Figure 6B). The movement of
(HhH)2 domains should be feasible as is evident from the
Topo-44 structures showing different orientations of the (HhH)2
domains. The location of the (HhH)2 domains after DNA binding
is not evident, but one possibility is that they would help enclose
the DNA to form a clamp around it, similar to the arrangement in
type IB enzymes.
In the model of the topoisomerase domain in complex with
DNA, the active site residues are in close contact with the back-
bone of DNA. The catalytic Tyr226 is pointing toward the phos-
phate of the DNA backbone; Arg131 and Arg144 are positioned
to stabilize the protein-DNA covalent complex. Surprisingly
Glu215 also appears to interact directly with the DNA phosphate
backbone. The other active site residues like His200 and Lys 218
are also near the DNA. The active site is located near the end of
the groove, where it widens. At this end, the DNA fits loosely in
the groove, which is spacious enough to accommodate the
movement of the strands. The ‘‘constrained swiveling’’ mecha-
nism used by type IB and IC enzymes necessitates rotation ofs reserved
Figure 6. Model Showing DNA Bound to the Topoiso-
merase Domain
(A) Model of a 17-mer double stranded DNA bound to the
Topo-31 structure (teal). The DNA is represented as green
sticks, whereas phosphate ions are represented as orange
sticks. DNA binds along the DNA binding groove and five of
the eight phosphate ions noted in the Topo-44 structures coin-
cide with the DNA backbone.
(B) Model of Topo-44 (Form II, B subunit: blue) binding to 17-
mer double stranded DNA. Note that the linker helix and the
(HhH)2 domains interfere with DNA binding to the topoisomer-
ase domain and are likely to move away to allow binding.
(C) Electrostatic surface representation of the Topo-31 struc-
ture. The positively charged DNA binding groove is clearly
visible and the phosphate ions are bound in this groove. The
orientation corresponds to a 90 rotation of the one shown in
(A) in the direction of the arrow. Note that the DNA binding
groove goes from one end of the molecule to the other and it
is narrower at one end (start of the linker helix) and wider at
the other end. The putative active site residues (green sticks)
are located at the wider end of the groove. Other residues
lining the groove and interacting with the phosphate ions are
shown as cyan sticks.
(D) Electrostatic surface representation of Topo-31 with phos-
phate ions (orange) and DNA (green). Three phosphate ions
(P3, P4, and P5) coincide with the phosphates of one of the
DNA strands, whereas P1 coincides with a phosphate of the
opposite DNA strand. The model shows that the DNA binding
groove of topoisomerase V is wide enough to bind DNA and
that the movement of linker helix and (HhH)2 domains are
required to accommodate the DNA. The electrostatic potential
was calculated with a dielectric constant of 80 for solvent and
2 for protein. The surface is colored with a blue to red gradient
from +10 to –10 KbT/ec.
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Minimal Catalytic Domain of Topoisomerase Vone strand about the other after forming the covalent protein-
DNA intermediate. The position of the active site at the wider
end of the putative DNA binding groove would facilitate the rota-
tion of the DNA strand at this end, while holding the rest of the
DNA in place through extensive interactions along the groove.
Even though type IB and IC enzymes have a similar overall
mechanism of action, the structures of fragments of topoisomer-
ase V suggest many differences. Type IB enzymes have two
domains that come together to form a C-shaped clamp around
the DNA (Perry et al., 2006; Redinbo et al., 1998; Stewart et al.,
1998). The protein has an open stage where these domains are
separate and this helps in the entry and release of the DNA
from the protein active site. A wide DNA binding cavity is not
observed in the topoisomerase V structures. Instead, the struc-
tures show a positively charged groove that is always present in
the protein and does not require domain rearrangements to form.
DNA can access this groove after a conformational change
involving the movement of the (HhH)2 domains exposing the
active site. The (HhH)2 domains could help enclose DNA during
the swiveling of the DNA, forming a similar enclosure to the
one observed for type IB enzymes. It is not known whether all
HhH motifs contact DNA simultaneously, but this appears
unlikely without a major rearrangement of the motifs. It is likely
that only some of the HhH motifs contact DNA at any given
time or that some of the motifs do not have the capacity to
bind DNA. Finally, similar to type IB enzymes (Cheng and
Shuman, 1998), the putative domain enclosing the DNA is
dispensable for activity, although it enhances the relaxationStructure 18,activity markedly. Thus, it is likely that type IB and IC enzymes
have several overall similarities in the way that they interact
with DNA, but the atomic details are markedly different.
There are still many details of the atomicmechanism of type IC
topoisomerases that need to be understood. The present func-
tional and structural studies provide new information about top-
oisomerase V, including the observations that the Topo-31 is the
minimal fragment capable of DNA relaxation, the (HhH)2 domains
enhance binding of the protein to DNA, the changes in relative
orientation of the domains is mediated by the linker helix, and
several phosphate ions bind in a positively charged groove.
Furthermore, the position of the phosphate ions in the groove
helped in the placement of DNA in the topoisomerase domain
and this provides an initial model of how topoisomerase V inter-
acts with DNA. Thus the present study helps to establish the role
of different domains more clearly, to illustrate a mechanism to
drive the conformational changes needed for activity, and to
suggest a possible manner of binding DNA. Additional work on
structures of protein-DNA complexes and intermediates in the
swiveling reaction are needed to understand the way this new
type of topoisomerases interacts with DNA to perform a complex
reaction.EXPERIMENTAL PROCEDURES
Protein Purification
The N-terminal 31 kDa (Topo-31: residues 1–269) and 44 kDa (Topo-44: resi-
dues 1–380) fragments of topoisomerase V protein were cloned into the829–838, July 14, 2010 ª2010 Elsevier Ltd All rights reserved 835
Table 1. Data Collection and Refinement Statistics
Topo-31
Topo-44
Form I
Topo-44
Form II
Topo-44
Form III
Data Collection
Space group C2221 C121 P41212 P212121
Cell dimensions a = 106.7 A˚,
b = 119.4 A˚,
c = 63.7 A˚
a = 104.2 A˚,
b = 47.7 A˚,
c = 81.2 A˚ (b = 112.48)
a = b = 70.1 A˚,
c = 349.6 A˚
a = 63.6 A˚,
b = 80.1 A˚,
c = 137.2 A˚
Resolution (A˚)a 79.56–2.4 (2.53–2.4) 75.05–1.82 (1.91–1.82) 29.5–2.6 (2.72–2.6) 28.9–1.4 (1.46–1.4)
Number of observed reflections 78,729 (11,538) 134,411 (13,220) 227,408 (19,917) 1,157,917 (126,319)
Number of unique reflections 16,259 (2,346) 32,998 (4,301) 28,151 (3,331) 136,662 (15,986)
Completeness (%) 99.8 (99.8) 98.3 (88.6) 99.9 (100.0) 98.8 (95.5)
Multiplicity 4.8 (4.9) 4.1 (3.1) 8.1 (6.0) 8.5 (7.9)
Rmerge (%)
b 4.7 (71.1) 4.0 (16.3) 7.4 (52.2) 4.5 (37.9)
Rmeas (%)
c 5.3 (79.6) 4.6 (19.4) 7.9 (57.2) 4.8 (40.5)
<<I>/s(<I>)>d 20.5 (2.5) 23.0 (6.8) 19 (3.2) 27.5 (5.3)
Refinement
Resolution (A˚) 79.56–2.4 (2.46–2.4) 28.06–1.82 (1.87–1.82) 29.14–2.6 (2.67–2.6) 28.9–1.4 (1.44–1.4)
Number of reflections
working/test
15,419/821 31,317/1,673 26,710/1,438 129,802/6,859
Rwork (%)
e 20.0 (24.3) 17.5 (17.9) 24.1 (36.6) 16.5 (19.3)
Rfree (%)
f 24.8 (31.1) 22.0 (24.8) 28.9 (45.1) 18.4 (22.1)
Protein residues/atomsg 269/2,203 376/3,212 727/5,970 738/7,511
Atoms in alternate
conformations
0 258 (20 protein
residues)
8 (1 protein
residue)
2846 (157 protein
residues)
Water molecules 29 238 30 573
Other atoms – – 3 PO4 7 PO4, 3 Gm
h,
3 Mg2+, 2 Cl
B factor (A˚2)
Protein atoms (chain) 68.4 22.8 A: 53.8; B: 58.2 A: 13.4; B: 14.9
Water molecules 59.1 29.3 40.0 23.7
Rmsds
Bond lengths (A˚) 0.015 0.006 0.01 0.009
Bond angles () 1.42 0.920 1.2 1.2
Ramachandran ploti
Favored regions (%) 94.3 98.9 96.2 98.5
Outliers (%) 0.0 0.0 0.3 0
aNumbers in parentheses correspond to highest resolution shell.
b Rmerge =
PjI – <I>j/PI, where I is the observed intensity and <I> is the average intensity obtained from multiple measurements.
c Rmeas is as described in Diederichs and Karplus (1997).
d <<I>/s(<I>)> = Mean Ih over the standard deviation of the mean Ih averaged over all reflections in a resolution shell.
e Rwork =
PkFoj – jFck/
PjFoj, where jFoj is the observed structure factor amplitude and jFcj is the calculated structure factor amplitude.
f Rfree, Rfactor based on 5% of the data excluded from refinement.
g Total number of protein atoms, including those in alternate conformations.
hGm, guanidinium ion.
i As reported by Molprobity (Davis et al., 2004).
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Minimal Catalytic Domain of Topoisomerase VpET15b plasmid and transformed into Escherichia coli BL21 Rosetta (DE3)
cells. The N-terminal 78 kDa (Topo-78: residues 1–685) fragment of topoiso-
merase V protein was cloned into the pET14b plasmid (Belova et al., 2002)
and transformed into Escherichia coli BL21(DE3) cells. For protein production,
cells were grown at 37C in LB medium containing 100 mg/ml ampicillin and
100 mg/ml chloramphenicol for Rosetta cells and LB medium with 100 mg/ml
ampicillin for BL21(DE3) cells to an optical density (OD600) of 0.6. The cells
were then cooled down on ice, followed by the addition of isopropyl b-D-1-thi-
ogalactopyranoside to a final 0.5 mM concentration, and grown overnight at836 Structure 18, 829–838, July 14, 2010 ª2010 Elsevier Ltd All right16C. Cells were harvested and resuspended in 50 mM Tris (pH 8), 500 mM
NaCl, 0.5 mM EDTA, and 1 mM DTT, flash frozen in liquid nitrogen, and stored
at –80C. After thawing the pellet, 1 mg/ml pepstatin, 1mMbenzamidine, 1mM
PMSF, and 0.1%Brij 58 were added to the cells and the protein was purified as
described earlier (Taneja et al., 2006). The protein was further purified by anion
exchange and gel filtration chromatography. Pure protein was concentrated
and stored in 50 mM Tris (pH 8), 250 mMNaCl, and 1 mMDTT. The selenome-
thionine-substituted Topo-44 was prepared from cells grown in a minimal
medium supplemented with nutrients and salts (Doublie, 1997); proteins reserved
Structure
Minimal Catalytic Domain of Topoisomerase Vpurification followed the same procedure as for the native protein except that
5 mM DTT was used in all the purification steps and for storage.
Relaxation Assays
Relaxation assays with the different topoisomerase V fragments were carried
out at pH values ranging from 4 to 10. The pH of the buffers was adjusted at
65C to account for the change in pH at higher temperature. The different
buffers used were: sodium acetate for pH 4 and 5, MES for pH 6, HEPES for
pH 7, Tris for pH 8, CHES for pH 9, and CAPS for pH 10. Topoisomerase
activity assays were performed by incubating varying amounts of protein
(Topo-31, Topo-44, or Topo-78) with 0.2 mg of negatively supercoiled
pUC19 DNA in 50 mM of the required buffer, 30 mM NaCl, 0.2 mM or 5 mM
EDTA, or 1 mM MgCl2. The reactions were carried out at 65
C for 15 min
and terminated by cooling and addition of SDS to a final 1% concentration.
The products were resolved on a 1% agarose gel and visualized by ethidium
bromide staining.
Electrophoretic Mobility Shift Assay
For EMSA, 4 mM of a 39-mer double stranded DNA oligonucleotide (50-GC
GACGCGAGGCTGGATGGCCTTCCCCATTATGATTCTT-30) was incubated
with different concentrations of topoisomerase V fragments in 50 mM sodium
acetate (pH 5), 30 mMNaCl, and 1 mMMgCl2 at 65
C for 30 min. Glycerol was
added to the reaction mixture to a final concentration of 8% and the products
were separated on a 4% acrylamide native gel. The gel was stained with
ethidium bromide to detect the DNA. When a stable protein-DNA complex
was formed, there was an upward shift in the band indicating a higher molec-
ular weight complex.
Crystallization
Topo-31 crystals were grown using the sitting drop vapor diffusion method
equilibrated against 23% PEG 6000 and 0.1 M sodium citrate (pH 5.5), at
22C. For data collection, the Topo-31 crystals were cryoprotected by adding
glycerol to the mother liquor to a final 20% concentration. Topo-44 was
crystallized by the hanging drop vapor diffusion method under three different
crystallization conditions (Forms I, II, and III). Crystal Form I grew under 0.1 M
phosphate citrate (pH 5), 0.2 M NaCl, 15% PEG 3350, and 8% dioxane. The
crystals were cryoprotected by increasing the PEG concentration to 30%.
Form II crystals grew under 0.1 M phosphate citrate (pH 5), 0.2 M NaCl,
16% PEG 8000, and 1 M guanidium hydrochloride. For cryoprotection, they
were transferred to a solution with 1.53 reservoir solution and 20% 2,3 buta-
nediol or 20% DMSO for 10 s and immediately flash frozen under liquid
nitrogen. Form III crystals grew under 0.1 M phosphate citrate (pH 5.5),
0.15 M sodium sulfate, 0.01 M MgCl2, 1 M guanidium hydrochloride, and
28% PEG 3350. The crystals were grown at 30C and were cryoprotected
by increasing the PEG concentration to 40%. Further details of crystallization
are presented in the Supplemental Experimental Procedures (available online).
Data Collection and Structure Determination
Diffraction data were collected at the Dupont Northwestern Dow and Life
Science Collaborative Access Team stations at the Advanced Photon Source
in Argonne National Laboratory. Data collection and refinement statistics are
shown in Table 1. All data were processed and integrated using XDS (Kabsch,
1993) and scaled with SCALA (CCP4, 1994). Data on the Topo-31 crystals
were collected to 2.4 A˚ resolution. The structure was solved by molecular
replacement (McCoy et al., 2007) using the topoisomerase domain from the
Topo-61 structure (residues 1–266) (Taneja et al., 2006) as the search model.
It was refined with refmac5 (Murshudov et al., 1997) and Phenix (Afonine et al.,
2005) to a final Rwork of 20.0% and Rfree of 24.8%. Topo-44 Form I crystals
diffract to 1.8 A˚. The structure of Form I crystals was solved by molecular
replacement (McCoy et al., 2007) using the topoisomerase domain from the
Topo-61 structure as the searchmodel. Model rebuilding was performed using
coot (Emsley and Cowtan, 2004) and refinement using refmac5 (Murshudov
et al., 1997). The final Rwork and Rfree are 17.5% and 22.0%, respectively.
For Topo-44 Form II and Form III crystals, selenomethionine-derivatized
crystals were used for single-wavelength anomalous dispersion phasing. Au-
toSharp (Vonrhein et al., 2007) was used for locating the selenium atoms,
model building was done using coot (Emsley and Cowtan, 2004), and refine-
ment was carried out using refmac5 (Murshudov et al., 1997). Three phosphateStructure 18,ions were noticed in the Form II structure; two of which are present in the topo-
isomerase active site and are separated by a distance of7.5 A˚. The structure
was refined to a final Rwork of 24.1% and Rfree of 28.9%. Topo-44 Form III crys-
tals diffracted to 1.4 A˚. The final Rwork and Rfree are 16.5% and 18.4%, respec-
tively. An interesting observation is the presence of both phosphate and
guanidium ions in the Form III Topo-44 structure. The linker helix and part of
the first HhH motif of the B monomer show alternate conformations and
were built as two separate chains with occupancy of 0.5 each. Further details
on data collection and structure determination are given in the Supplemental
Experimental Procedures.
All figures were made with Pymol (DeLano, 2002) and the electrostatic
surfaces were calculated with APBS (Baker et al., 2001).ACCESSION NUMBERS
The final structure factors and coordinates of Topo-31 and Topo-44 Form I,
Form II, and Form III have been deposited in the Protein Data Bank with acces-
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